196 related articles for article (PubMed ID: 31956259)
1. Antiviral Activity of Cananga odorata Against Hepatitis B Virus.
Indrasetiawan P; Aoki-Utsubo C; Hanafi M; Hartati S; Wahyuni TS; Kameoka M; Yano Y; Hotta H; Hayashi Y
Kobe J Med Sci; 2019 Nov; 65(2):E71-E79. PubMed ID: 31956259
[TBL] [Abstract][Full Text] [Related]
2. Nobiletin, a novel inhibitor, inhibits HBsAg production and hepatitis B virus replication.
Hu Z; Hu J; Ren F; Xu H; Tan M; Wang Q; Ren J
Biochem Biophys Res Commun; 2020 Mar; 523(3):802-808. PubMed ID: 31954513
[TBL] [Abstract][Full Text] [Related]
3. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of crude extracts from some edible Thai plants against replication of hepatitis B virus and human liver cancer cells.
Waiyaput W; Payungporn S; Issara-Amphorn J; Panjaworayan NT
BMC Complement Altern Med; 2012 Dec; 12():246. PubMed ID: 23216691
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activities of extracts isolated from Terminalis chebula Retz., Sanguisorba officinalis L., Rubus coreanus Miq. and Rheum palmatum L. against hepatitis B virus.
Kim TG; Kang SY; Jung KK; Kang JH; Lee E; Han HM; Kim SH
Phytother Res; 2001 Dec; 15(8):718-20. PubMed ID: 11746867
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
[TBL] [Abstract][Full Text] [Related]
7. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
Kaneko M; Watashi K; Kamisuki S; Matsunaga H; Iwamoto M; Kawai F; Ohashi H; Tsukuda S; Shimura S; Suzuki R; Aizaki H; Sugiyama M; Park SY; Ito T; Ohtani N; Sugawara F; Tanaka Y; Mizokami M; Sureau C; Wakita T
J Virol; 2015 Dec; 89(23):11945-53. PubMed ID: 26378168
[TBL] [Abstract][Full Text] [Related]
8. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
Qiao L; Sui J; Luo G
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
[TBL] [Abstract][Full Text] [Related]
9. The anti-hepatitis B virus therapeutic potential of anthraquinones derived from Aloe vera.
Parvez MK; Al-Dosari MS; Alam P; Rehman M; Alajmi MF; Alqahtani AS
Phytother Res; 2019 Nov; 33(11):2960-2970. PubMed ID: 31410907
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation.
Tanaka T; Okuyama-Dobashi K; Murakami S; Chen W; Okamoto T; Ueda K; Hosoya T; Matsuura Y; Ryo A; Tanaka Y; Hagiwara M; Moriishi K
Antiviral Res; 2016 Sep; 133():156-64. PubMed ID: 27515132
[TBL] [Abstract][Full Text] [Related]
11. Development of a mass spectrometric screening assay for hepatitis B virus entry inhibitors.
Goh B; Choi J; Kang JA; Park SG; Seo J; Kim TY
J Pharm Biomed Anal; 2020 Jan; 178():112959. PubMed ID: 31722821
[TBL] [Abstract][Full Text] [Related]
12. Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line.
Ogura N; Watashi K; Noguchi T; Wakita T
Biochem Biophys Res Commun; 2014 Sep; 452(3):315-21. PubMed ID: 25150444
[TBL] [Abstract][Full Text] [Related]
13. Anti-hepatitis B virus activity of swertisin isolated from Iris tectorum Maxim.
Xu HY; Ren JH; Su Y; Ren F; Zhou YJ; Jiang H; Cheng ST; Zhang CR; Chen J
J Ethnopharmacol; 2020 Jul; 257():112787. PubMed ID: 32224198
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice.
Lai YH; Sun CP; Huang HC; Chen JC; Liu HK; Huang C
BMC Complement Altern Med; 2018 Sep; 18(1):248. PubMed ID: 30189898
[TBL] [Abstract][Full Text] [Related]
15. Effect of cantharidin, cephalotaxine and homoharringtonine on "in vitro" models of hepatitis B virus (HBV) and bovine viral diarrhoea virus (BVDV) replication.
Romero MR; Serrano MA; Efferth T; Alvarez M; Marin JJ
Planta Med; 2007 Jun; 73(6):552-8. PubMed ID: 17458779
[TBL] [Abstract][Full Text] [Related]
16. ANTIVIRAL ACTIVITY OF
Li WG; Wang HQ
Afr J Tradit Complement Altern Med; 2016; 13(5):48-53. PubMed ID: 28487893
[TBL] [Abstract][Full Text] [Related]
17. Identification of Antiviral Agents Targeting Hepatitis B Virus Promoter from Extracts of Indonesian Marine Organisms by a Novel Cell-Based Screening Assay.
Yamashita A; Fujimoto Y; Tamaki M; Setiawan A; Tanaka T; Okuyama-Dobashi K; Kasai H; Watashi K; Wakita T; Toyama M; Baba M; de Voogd NJ; Maekawa S; Enomoto N; Tanaka J; Moriishi K
Mar Drugs; 2015 Nov; 13(11):6759-73. PubMed ID: 26561821
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide.
Nio Y; Akahori Y; Okamura H; Watashi K; Wakita T; Hijikata M
Biochem Biophys Res Commun; 2018 Jun; 501(3):820-825. PubMed ID: 29723527
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of Phyllanthus urinaria L. extract on the replication of lamivudine-resistant hepatitis B virus in vitro.
Jung J; Kim NK; Park S; Shin HJ; Hwang SG; Kim K
BMC Complement Altern Med; 2015 Jul; 15():255. PubMed ID: 26220282
[TBL] [Abstract][Full Text] [Related]
20. The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide.
Ko C; Park WJ; Park S; Kim S; Windisch MP; Ryu WS
Antivir Ther; 2015; 20(8):835-42. PubMed ID: 25929767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
